The national subcutaneous insulin chart is designed to:
The chart has a number of safety features and enabling functions including:
The national subcutaneous insulin chart has been piloted in public and private hospitals in two waves. The safety performance of the subcutaneous insulin chart points to 35 areas of positive performance (of statistical significance) which led to improved management of BGLs in hospitalised patients.
The Australian Commission on Safety and Quality in Health Care produced the national subcutaneous insulin chart to support the delivery of appropriate care and improve the management of blood glucose levels (BGLs) in hospitalised patients. The chart is based on the best evidence available at the time of development, and included human factor analysis and piloting of the chart in public and private hospitals. Healthcare professionals are advised to use clinical discretion and consideration of the circumstances of the individual patient when using the chart to manage BGLs.
The following support materials have been developed by the Commission and the University of Queensland to help hospitals and health services implement the national subcutaneous insulin chart:
A series of instructional videos are also available on the Commission’s YouTube channel.